Image may be NSFW.
Clik here to view.
Clik here to view.
MDxHealth strengthens position in epigenetics testing
After launching a breakthrough epigenetics diagnostic for prostate cancer in the U.S. last May, Belgium-based MDxHealth (NYSE Euronet:MDXH), with U.S. headquarters in Irvine, Calif., continues to...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
In conversation with Geoffrey Hamilton-Fairley
Mr. Hamilton-Fairley As CEO of closely-held Oncimmune, an early cancer diagnostic company in Britain, Geoffrey Hamilton-Fairley has had a personal commitment to cancer detection. His father was the...
View Article
More Pages to Explore .....
